Your session is about to expire
← Back to Search
Dermal Regeneration Template
Direct Application of Integra Bilayer Matrices on Bare Calvarium Without Preliminary Burring
N/A
Waitlist Available
Led By Joshua H Choo, MD
Research Sponsored by Joshua Choo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 - 12 months for study
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if a special artificial skin (IDRT) can help heal large, deep scalp wounds that expose the skull bone without needing extra steps to prepare the bone. It aims to see if this method can work reliably for these difficult-to-treat wounds.
Eligible Conditions
- Surgical Wound
- Pressure Ulcer
- Injury
- Pressure Sore
- Wound Care
- Venous Ulcers
- Draining Wounds
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 - 12 months for study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 - 12 months for study
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percentage of subjects with complete closure of defect
Time to complete closure
Secondary study objectives
Percent overall skin graft take
Other study objectives
Assessment of neodermis formation
Histologic appearance of wounds treated with Integra immediately prior to skin graft
Skin graft stability
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single-arm prospectiveExperimental Treatment1 Intervention
Single-arm prospective pilot study. All patients receive Integra dermal regeneration template (IDRT) that sign an inform consent.
Find a Location
Who is running the clinical trial?
Joshua ChooLead Sponsor
Integra LifeSciences CorporationIndustry Sponsor
108 Previous Clinical Trials
11,284 Total Patients Enrolled
3 Trials studying Surgical Wound
449 Patients Enrolled for Surgical Wound
Joshua H Choo, MDPrincipal InvestigatorUniversity of Louisville School of Medicine Division of Plastic Surgery
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a condition called osteomyelitis or osteoradionecrosis, or your bones don't have enough strength to support the implant.You have a medical history that could slow down the healing process of wounds or injuries, such as kidney disease or taking medicines that weaken your immune system.You are taking or planning to take medication that may slow down or negatively affect the healing of wounds.You are expected to have a defect in your skull that goes beyond the outer layer due to surgery to remove a tumor or damaged tissue.You are allergic to bovine collagen or chondroitin.You have received radiation treatment in the past.You have visible signs of an infected wound.
Research Study Groups:
This trial has the following groups:- Group 1: Single-arm prospective
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.